Annual EBITDA
$1.18 B
-$11.93 B-91.02%
December 31, 2023
Summary
- As of February 26, 2025, BNTX annual EBITDA is $1.18 billion, with the most recent change of -$11.93 billion (-91.02%) on December 31, 2023.
- During the last 3 years, BNTX annual EBITDA has risen by +$1.30 billion (+1080.98%).
- BNTX annual EBITDA is now -93.37% below its all-time high of $17.75 billion, reached on December 31, 2021.
Performance
BNTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$232.17 M
+$1.04 B+128.80%
September 1, 2024
Summary
- As of February 26, 2025, BNTX quarterly EBITDA is $232.17 million, with the most recent change of +$1.04 billion (+128.80%) on September 1, 2024.
- Over the past year, BNTX quarterly EBITDA has stayed the same.
- BNTX quarterly EBITDA is now -95.90% below its all-time high of $5.67 billion, reached on March 31, 2022.
Performance
BNTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$396.94 M
-$62.56 M-18.71%
September 1, 2024
Summary
- As of February 26, 2025, BNTX TTM EBITDA is -$396.94 million, with the most recent change of -$62.56 million (-18.71%) on September 1, 2024.
- Over the past year, BNTX TTM EBITDA has stayed the same.
- BNTX TTM EBITDA is now -101.86% below its all-time high of $21.35 billion, reached on March 31, 2022.
Performance
BNTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BNTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -91.0% | 0.0% | 0.0% |
| 3 y3 years | +1081.0% | 0.0% | 0.0% |
| 5 y5 years | +4262.3% | +1090.1% | +6.4% |
BNTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -93.4% | at low | -95.9% | +128.8% | -101.9% | at low |
| 5 y | 5-year | -93.4% | +831.4% | -95.9% | +128.8% | -101.9% | +6.4% |
| alltime | all time | -93.4% | +831.4% | -95.9% | +128.8% | -101.9% | +6.4% |
BioNTech SE EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $232.17 M(-128.8%) | -$396.94 M(+18.7%) |
| Jun 2024 | - | -$806.06 M(+157.0%) | -$334.37 M(-672.5%) |
| Mar 2024 | - | -$313.69 M(-163.9%) | $58.41 M(-95.1%) |
| Dec 2023 | $1.18 B(-91.0%) | $490.64 M(+66.5%) | $1.20 B(-63.7%) |
| Sep 2023 | - | $294.73 M(-171.3%) | $3.30 B(-40.1%) |
| Jun 2023 | - | -$413.28 M(-150.1%) | $5.50 B(-34.7%) |
| Mar 2023 | - | $824.97 M(-68.2%) | $8.43 B(-36.5%) |
| Dec 2022 | $13.11 B(-26.2%) | $2.59 B(+3.7%) | $13.27 B(-16.9%) |
| Sep 2022 | - | $2.50 B(-0.5%) | $15.96 B(-15.9%) |
| Jun 2022 | - | $2.51 B(-55.7%) | $18.99 B(-11.0%) |
| Mar 2022 | - | $5.67 B(+7.3%) | $21.35 B(+20.8%) |
| Dec 2021 | $17.75 B | $5.28 B(-4.4%) | $17.67 B(+39.7%) |
| Sep 2021 | - | $5.53 B(+13.5%) | $12.65 B(+83.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $4.87 B(+144.0%) | $6.89 B(+256.2%) |
| Mar 2021 | - | $2.00 B(+665.3%) | $1.94 B(-1868.1%) |
| Dec 2020 | -$120.03 M(-25.4%) | $260.76 M(-212.5%) | -$109.44 M(-74.2%) |
| Sep 2020 | - | -$231.78 M(+159.2%) | -$423.89 M(+96.6%) |
| Jun 2020 | - | -$89.43 M(+82.5%) | -$215.56 M(+26.8%) |
| Mar 2020 | - | -$49.00 M(-8.7%) | -$169.98 M(+7.2%) |
| Dec 2019 | -$160.98 M(+469.1%) | -$53.69 M(+129.0%) | -$158.55 M(+64.0%) |
| Sep 2019 | - | -$23.45 M(-46.5%) | -$96.67 M(+4.9%) |
| Jun 2019 | - | -$43.85 M(+16.7%) | -$92.18 M(+90.7%) |
| Mar 2019 | - | -$37.57 M(-558.5%) | -$48.33 M(+349.0%) |
| Dec 2018 | -$28.29 M(-66.6%) | $8.19 M(-143.2%) | -$10.76 M(-43.2%) |
| Sep 2018 | - | -$18.96 M | -$18.96 M |
| Dec 2017 | -$84.60 M | - | - |
FAQ
- What is BioNTech SE annual EBITDA?
- What is the all time high annual EBITDA for BioNTech SE?
- What is BioNTech SE annual EBITDA year-on-year change?
- What is BioNTech SE quarterly EBITDA?
- What is the all time high quarterly EBITDA for BioNTech SE?
- What is BioNTech SE quarterly EBITDA year-on-year change?
- What is BioNTech SE TTM EBITDA?
- What is the all time high TTM EBITDA for BioNTech SE?
- What is BioNTech SE TTM EBITDA year-on-year change?
What is BioNTech SE annual EBITDA?
The current annual EBITDA of BNTX is $1.18 B
What is the all time high annual EBITDA for BioNTech SE?
BioNTech SE all-time high annual EBITDA is $17.75 B
What is BioNTech SE annual EBITDA year-on-year change?
Over the past year, BNTX annual EBITDA has changed by -$11.93 B (-91.02%)
What is BioNTech SE quarterly EBITDA?
The current quarterly EBITDA of BNTX is $232.17 M
What is the all time high quarterly EBITDA for BioNTech SE?
BioNTech SE all-time high quarterly EBITDA is $5.67 B
What is BioNTech SE quarterly EBITDA year-on-year change?
Over the past year, BNTX quarterly EBITDA has changed by $0.00 (0.00%)
What is BioNTech SE TTM EBITDA?
The current TTM EBITDA of BNTX is -$396.94 M
What is the all time high TTM EBITDA for BioNTech SE?
BioNTech SE all-time high TTM EBITDA is $21.35 B
What is BioNTech SE TTM EBITDA year-on-year change?
Over the past year, BNTX TTM EBITDA has changed by $0.00 (0.00%)